Who
Oliver Dolan
Senior Vice President, Finance
Company insider
Files Form 4 as: Senior Vice President, Finance, Korro Bio.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $272K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Apr 2025
- Last trade
- 11 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Sep 2026filed 14 Sep 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $695 at $13.72 | filing |
| 11 Sep 2026filed 14 Sep 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $695 at $13.72 | filing |
| 9 Sep 2026filed 10 Sep 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $826 at $13.60 | filing |
| 9 Sep 2026filed 10 Sep 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $826 at $13.60 | filing |
| 8 Sep 2026filed 10 Sep 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $99K7,347 at $13.51 | filing |
| 8 Sep 2026filed 10 Sep 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $99K7,347 at $13.51 | filing |
| 15 Jul 2026filed 17 Jul 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Code A | —5,500 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $37K3,383 at $10.83 | filing |
| 16 Jun 2026filed 17 Jun 2026 | KRRO Korro BioBiotechnology | SEC FORM 4 Sold | $37K3,383 at $10.83 | filing |
| 2 Feb 2026filed 3 Feb 2026 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 15 Dec 2025filed 16 Dec 2025 | KRRO Korro BioBiotechnology | SEC FORM 4 Code A | —21,482 at $0.00 | filing |
| 1 Apr 2025filed 1 Apr 2025 | KRRO Korro Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
Korro Bio (NASDAQ:KRRO) Major Shareholder Lynx1 Capital Management Lp Purchases 25,124 Shares of Company StockKRRO · tickerreport.com · 27 Oct 2026Korro Bio (NASDAQ:KRRO) Major Shareholder Lynx1 Capital Management Lp Purchases 25,124 Shares of StockKRRO · dailypolitical.com · 27 Oct 2026Insider Buying: Korro Bio (NASDAQ:KRRO) Major Shareholder Purchases 52,175 Shares of StockKRRO · themarketsdaily.com · 27 Oct 2026
0 headlines in the last 90 days name Oliver Dolan; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.